In summary, our results establish the IRE1/Xbp1s axis as a central regulator of poly(GR) degradation and provide strong support for its therapeutic targeting in C9orf72-associated ALS and FTD. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.